Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New nerve block technique may ease pain after heart surgery

NCT ID NCT07259057

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a nerve block called erector spinae plane block (ESPB) can improve pain control and recovery in adults undergoing open-heart surgery. Sixty-six participants received either the nerve block or standard IV opioids. Researchers measured pain scores, need for extra painkillers, and other health indicators for 48 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bupivacaine
What this could lead to
If it works, this could offer a better way to manage pain after open-heart surgery, reducing opioid use and speeding recovery.
What could go wrong
This is a small, completed trial with 66 participants, so results may not apply to everyone. The nerve block carries risks like infection or bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Jan 2023

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 75 years * Scheduled for elective open-heart surgery via median sternotomy (CABG or valve surgery) * ASA physical status II-III * Provided written informed consent * BMI \< 35 kg/m² Exclusion Criteria: * Age \<18 or \>75 years * Known coagulopathy or anticoagulation contraindicating regional block * Infection or dermatological lesion at the injection site * Allergy to local anesthetics * Chronic use of opioids, anticonvulsants, antidepressants, or corticosteroids * Significant psychiatric or cognitive disorder preventing cooperation * Severe arrhythmia or hemodynamic instability prior to surgery * Local anesthetic toxicity risk factors or anatomic deformity preventing block placement * Non-elective or emergency cardiac surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karadeniz Technical University Faculty of Medicine, Farabi Hospital

    Trabzon, Trabzon, 61080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.